Reaktionsgleichung
[CH3:1][O:2][C:3]([C:5]1[CH:10]=[CH:9][C:8](Br)=[C:7]([O:12][CH2:13][CH:14]2[CH2:16][CH2:15]2)[N:6]=1)=[O:4].C(O)(=O)C(O)=O.[NH:23]1[C:26]2([CH2:29][O:28][CH2:27]2)[CH2:25][CH2:24]1>>[CH3:1][O:2][C:3]([C:5]1[CH:10]=[CH:9][C:8]([N:23]2[C:26]3([CH2:29][O:28][CH2:27]3)[CH2:25][CH2:24]2)=[C:7]([O:12][CH2:13][CH:14]2[CH2:16][CH2:15]2)[N:6]=1)=[O:4]Komponenten
3
Versuchsvorschrift
The title compound was synthesized in analogy to the procedure described in Example 32 a), using 5-bromo-6-(cyclopropylmethoxy)-pyridine-2-carboxylic acid methyl ester (Example 9 d) and 6-oxa-1-azaspiro[3.3]heptane, oxalate salt (CAN 1359655-43-8) as starting materials. MS (EI): m/e=305.0 [M+H]+.
Quellen und Nachweise
- ORD-Eintrag
- ord-7e0944ecc562480e9c4a513919de8bfb
- Quelldatensatz
- uspto-grants-2016_03
- Patentnummer
- US09290451B2
Verknüpfte Notizen
Wird geladen…